Blood Test-Guided dosing may boost depression treatment in kids and adults
NCT ID NCT07478796
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether measuring drug levels in the blood can help doctors give the right dose of antidepressants (sertraline, escitalopram, or fluoxetine) to hospitalized children and adults with major depression. About 180 participants will receive one of these medications, and their doses will be adjusted based on blood tests and symptom checks. The goal is to make treatment safer and more effective by personalizing dosing, especially for younger patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION - MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Szpital Kliniczny im. Karola Jonschera UMP (Poznan University of Medical Sciences)
RECRUITINGPoznan, Greater Poland Voivodeship, 60-572, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Eye movements may reveal who benefits from depression medication
- Special forces veterans test Psychedelic-Device combo for PTSD and brain injury
- Fish oil and Body's own healing molecules could lift long COVID depression
- Virtual reality could make depression therapy more immersive and effective
- Brain stimulation plus exercise may lift depression and boost walking after stroke
- Storytelling therapy shows promise for refugee teens' mental health